Literature DB >> 11401991

Porphyromonas gingivalis gingipain-R enhances interleukin-8 but decreases gamma interferon-inducible protein 10 production by human gingival fibroblasts in response to T-cell contact.

M Oido-Mori1, R Rezzonico, P L Wang, Y Kowashi, J M Dayer, P C Baehni, C Chizzolini.   

Abstract

Proteases produced by Porphyromonas gingivalis, an oral pathogen, are considered important virulence factors and may affect the responses of cells equipped with proteinase-activated receptors. The aim of this study was to investigate the effect of the arginine-specific cysteine protease gingipain-R produced by P. gingivalis on chemokine production by human gingival fibroblasts (HGF) and the effect of gingipain-R treatment on the subsequent contact-dependent activation of HGF by T cells. HGF incubated in the presence of purified 47-kDa gingipain-R showed increased levels of interleukin-8 (IL-8) mRNA. Cyclooxygenase-2 (COX-2) mRNA was also induced. Further exposure of HGF to activated T cells resulted in the dose- and time-dependent enhancement of IL-8 transcription and release. T-cell membrane-bound tumor necrosis factor (TNF) was the ligand inducing IL-8 production by HGF, since TNF neutralization abrogated HGF responses to T-cell contact. The enhanced IL-8 release was due, at least in part, to prostaglandin-E(2) production, which was mostly blocked by indomethacin. Gingipain-R proteolytic activity was required since heat inactivation, specific synthetic protease inhibitors, and the natural substrate competitor histatin 5 abrogated its effects. The enhanced production of IL-8 in response to T-cell contact was specific since monocyte chemotactic protein-1 (MCP-1) production was unaffected while interferon-gamma-inducible protein-10 (IP-10) was inhibited. The sum of these activities may result in the recruitment of differential cell types to sites of inflammation since IL-8 preferentially recruits neutrophils and IP-10 attracts activated T cells and may be relevant to the pathogenesis of periodontitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11401991      PMCID: PMC98524          DOI: 10.1128/IAI.69.7.4493-4501.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

1.  Juxtacrine stimulation of cytokine production in cocultures of human dermal fibroblasts and T cells.

Authors:  B Spörri; M Bickel; A Limat; E R Waelti; T Hunziker; U N Wiesmann
Journal:  Cytokine       Date:  1996-08       Impact factor: 3.861

Review 2.  Lymphocyte-fibroblast interactions.

Authors:  S Murakami; H Okada
Journal:  Crit Rev Oral Biol Med       Date:  1997

3.  Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.

Authors:  S Nystedt; K Emilsson; A K Larsson; B Strömbeck; J Sundelin
Journal:  Eur J Biochem       Date:  1995-08-15

4.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Authors:  M Loetscher; B Gerber; P Loetscher; S A Jones; L Piali; I Clark-Lewis; M Baggiolini; B Moser
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

5.  Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis.

Authors:  M A Jagels; J Travis; J Potempa; R Pike; T E Hugli
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

6.  Prostaglandin E2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro.

Authors:  A Agro; C Langdon; F Smith; C D Richards
Journal:  J Rheumatol       Date:  1996-05       Impact factor: 4.666

7.  Interactions of mast cell tryptase with thrombin receptors and PAR-2.

Authors:  M Molino; E S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; J A Hoxie; N Schechter; M Woolkalis; L F Brass
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

8.  The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor.

Authors:  D Burger; R Chicheportiche; J G Giri; J M Dayer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Cysteine protease of Porphyromonas gingivalis 381 enhances binding of fimbriae to cultured human fibroblasts and matrix proteins.

Authors:  M Kontani; H Ono; H Shibata; Y Okamura; T Tanaka; T Fujiwara; S Kimura; S Hamada
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

10.  Construction and characterization of arginine-specific cysteine proteinase (Arg-gingipain)-deficient mutants of Porphyromonas gingivalis. Evidence for significant contribution of Arg-gingipain to virulence.

Authors:  K Nakayama; T Kadowaki; K Okamoto; K Yamamoto
Journal:  J Biol Chem       Date:  1995-10-06       Impact factor: 5.157

View more
  15 in total

1.  A functional virulence complex composed of gingipains, adhesins, and lipopolysaccharide shows high affinity to host cells and matrix proteins and escapes recognition by host immune systems.

Authors:  Ryosuke Takii; Tomoko Kadowaki; Atsuyo Baba; Takayuki Tsukuba; Kenji Yamamoto
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Upregulation of intercellular adhesion molecule 1 and proinflammatory cytokines by the major surface proteins of Treponema maltophilum and Treponema lecithinolyticum, the phylogenetic group IV oral spirochetes associated with periodontitis and endodontic infections.

Authors:  Sung-Hoon Lee; Kack-Kyun Kim; Bong-Kyu Choi
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  The RgpA-Kgp proteinase-adhesin complexes of Porphyromonas gingivalis Inactivate the Th2 cytokines interleukin-4 and interleukin-5.

Authors:  Vivian Tam; Neil M O'Brien-Simpson; Yu-Yen Chen; Colin J Sanderson; Beverley Kinnear; Eric C Reynolds
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

4.  Luteolin and fisetin inhibit the effects of lipopolysaccharide obtained from Porphyromonas gingivalis in human gingival fibroblasts.

Authors:  Gloria Gutiérrez-Venegas; Anabel Contreras-Sánchez
Journal:  Mol Biol Rep       Date:  2012-10-11       Impact factor: 2.316

5.  Expression and regulation of the NALP3 inflammasome complex in periodontal diseases.

Authors:  N Bostanci; G Emingil; B Saygan; O Turkoglu; G Atilla; M A Curtis; G N Belibasakis
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

6.  Arginine-specific gingipains from Porphyromonas gingivalis deprive protective functions of secretory leucocyte protease inhibitor in periodontal tissue.

Authors:  T Into; M Inomata; Y Kanno; T Matsuyama; M Machigashira; Y Izumi; T Imamura; M Nakashima; T Noguchi; K Matsushita
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

Review 7.  Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications.

Authors:  Ian M Carroll; Nitsan Maharshak
Journal:  World J Gastroenterol       Date:  2013       Impact factor: 5.742

8.  Suppression of T-cell chemokines by Porphyromonas gingivalis.

Authors:  Catherine E Jauregui; Qian Wang; Christopher J Wright; Hiroki Takeuchi; Silvia M Uriarte; Richard J Lamont
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

9.  Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains.

Authors:  Rodrigo A Giacaman; Anil C Asrani; Karen F Ross; Mark C Herzberg
Journal:  Microbiology (Reading)       Date:  2009-07-16       Impact factor: 2.777

Review 10.  Corruption of innate immunity by bacterial proteases.

Authors:  Jan Potempa; Robert N Pike
Journal:  J Innate Immun       Date:  2009       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.